PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-07-31	NT$11.30	+1.35%	123,337
26-07-30	NT$11.15	-2.19%	159,560
26-07-29	NT$11.40	-.--%	323,949
26-07-28	NT$11.40	-2.15%	164,124
26-07-27	NT$11.65	-0.85%	166,980

End-of-day quote Taiwan S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Taiwan S.E. Other stock markets 2026-07-31			5-day change	1st Jan Change
11.30 ^TWD	+1.35%		-3.83%	-16.30%

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	2.24B 69.5M 60.42M 56.24M 51.63M 97.5M 6.63B 99.01M 663M 260M 3.3B 261M 255M 11.08B	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	1.2B 37.02M 32.18M 29.95M 27.5M 51.93M 3.53B 52.73M 353M 139M 1.76B 139M 136M 5.9B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.14%	Yield 2024 *	-	Yield 2025	-

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-09-21	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
25-08-13	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-06	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
25-05-04	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
25-05-04	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-06	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
25-03-06	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
25-02-27	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-11	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

22-08-09	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
22-07-05	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
22-05-24	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
22-04-08	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
22-03-09	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Stock

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation: PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases: PhytoHealth Corporation

Quotes and Performance

Course Extremes

Managers and Directors: PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+1.35%
1 week	-3.83%
1 month	-5.83%
3 months	-7.76%
6 months	-18.71%
Current year	-16.30%

1 week	11.05	11.65
1 month	11.05	12.9
Current year	11.05	15.25
1 year	11.05	17.9
3 years	11	24
5 years	11	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	2017-06-12
Chih Yuan Huang DFI	Director of Finance/CFO	-	2021-05-10
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	2021-07-29

Director	Title	Age	Since
Cheng Chia Li CHM	Chairman	-	2011-06-09
Yue Ju Lai BRD	Director/Board Member	-	2010-03-15
Yi Li Lee CHM	Chairman	55	2020-05-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	+1.35%	-3.83%	-11.02%	-48.64%	69.5M
REGENERON PHARMACEUTICALS, INC.	+3.29%	+16.25%	+36.46%	+4.17%	76.15B
UCB	+2.72%	-9.39%	+20.58%	+176.83%	48.89B
SAMSUNG BIOLOGICS CO.,LTD.	-2.75%	+48.50%	+48.50%	+48.50%	47.83B
CSL LIMITED	+1.01%	+6.84%	-53.06%	-53.43%	41.37B
BIOGEN INC.	-2.40%	+0.38%	+53.81%	-25.27%	29.99B
INCYTE CORPORATION	-2.82%	+1.57%	+58.12%	+81.97%	24.23B
MODERNA, INC.	-5.35%	+1.39%	+98.59%	-50.26%	21.89B
INNOVENT BIOLOGICS, INC.	-1.61%	-4.48%	-8.13%	+160.21%	19.25B
SWEDISH ORPHAN BIOVITRUM AB	-0.42%	+2.89%	+77.99%	+128.45%	17.14B
Average	-0.69%	+1.03%	+32.18%	+42.25%	32.68B
Weighted average by Cap.	+0.00%	+2.98%	+31.41%	+44.31%

	2024	2025
Net sales	154M 4.76M 4.13M 3.85M 3.53M 6.67M 454M 6.77M 45.35M 17.8M 226M 17.86M 17.47M 758M	135M 4.17M 3.62M 3.37M 3.1M 5.85M 398M 5.94M 39.75M 15.6M 198M 15.65M 15.31M 664M
Net income	-73.5M -2.28M -1.98M -1.84M -1.69M -3.19M -217M -3.24M -21.71M -8.52M -108M -8.55M -8.36M -363M	-58.2M -1.8M -1.57M -1.46M -1.34M -2.53M -172M -2.57M -17.19M -6.75M -85.65M -6.77M -6.62M -287M
Net Debt	-1.06B -32.88M -28.58M -26.61M -24.43M -46.13M -3.14B -46.84M -314M -123M -1.56B -123M -121M -5.24B	-1.05B -32.48M -28.24M -26.28M -24.13M -45.57M -3.1B -46.28M -310M -122M -1.54B -122M -119M -5.18B